Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
about
Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behaviorVirus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.Clinicopathological analysis of 12 patients with Epstein-Barr virus-positive primary intestinal T/natural killer-cell lymphoma (EBV+ ITNKL).Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathwayShort-Course Versus Long-Course Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study.
P2860
Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prognostic biomarkers in patie ...... concurrent chemoradiotherapy.
@ast
Prognostic biomarkers in patie ...... concurrent chemoradiotherapy.
@en
type
label
Prognostic biomarkers in patie ...... concurrent chemoradiotherapy.
@ast
Prognostic biomarkers in patie ...... concurrent chemoradiotherapy.
@en
prefLabel
Prognostic biomarkers in patie ...... concurrent chemoradiotherapy.
@ast
Prognostic biomarkers in patie ...... concurrent chemoradiotherapy.
@en
P2093
P2860
P356
P1433
P1476
Prognostic biomarkers in patie ...... concurrent chemoradiotherapy.
@en
P2093
Izumi Wasada
Kana Miyazaki
Katsuyoshi Takata
Kazuo Oshimi
Kenichi Ishizawa
Kensei Tobinai
Kuniaki Itoh
Kunihiro Tsukasaki
Masahiko Oguchi
Naoki Ishizuka
P2860
P304
P356
10.1111/CAS.12526
P577
2014-10-04T00:00:00Z